	US 11,701,423 B2
	Hyperimmunized egg product for treatment or prevention of coronavirus infection
Subramanian V. Iyer, Royal Palm Beach, FL (US); Satishchandran Chandrasekhar, Jupiter, FL (US); Uday Saxena, Bengaluru (IN); and Gopi Kadiyala, Karnataka (IN)
Assigned to LAY SCIENCES, INC., Jupiter, FL (US)
Filed by LAY SCIENCES INC., Jupiter, FL (US)
Filed on Mar. 11, 2022, as Appl. No. 17/693,280.
Claims priority of provisional application 63/160,155, filed on Mar. 12, 2021.
Prior Publication US 2022/0288193 A1, Sep. 15, 2022
Int. Cl. A61K 39/215 (2006.01); A23B 5/00 (2006.01); A61K 39/00 (2006.01)

CPC A61K 39/215 (2013.01) [A23B 5/00 (2013.01); A61K 2039/552 (2013.01)]

7 Claims

1. A method of preparing a hyperimmunized egg product comprising:

a) hyperimmunizing an egg-producing animal with a composition comprising an antigen having the amino acid sequence of SEQ ID NO: 19 and

b) preparing a hyperimmunized egg product from one or more eggs produced by the animal by dehydrating, spray drying, or freeze drying of whole egg, yolk or a purified IgY fraction from the one or more eggs.